Drreddys Laboratories | RDY - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
ANI Pharmaceuticals USD 91.66M 18.01M 2026-06
Aurora Cannabis CAD 41.4M 781K 2026-03
Bayer EUR 3.7B 356M 2026-03
Canopy Growth CAD 31.17M 2.27M 2026-03
Cipla INR 13.25B 101.8M 2025-12
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Drreddys Laboratories INR 14.47B 12.45B 2026-03
GlaxoSmithKline GBP 2.19B 75M 2026-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.24B 101M 2026-06
Pacira USD 91.81M 7.93M 2026-06
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 43.3M 13.02M 2026-06
Richter Gedeon HUF 55.32B 3.03B 2026-03
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06